Cargando…

Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study

BACKGROUND: We have previously shown that nuclear factor (NF)-κB activation of mouse Lewis lung carcinoma (LLC) specifically promotes the induction of malignant pleural effusions (MPE) by these cells. In the present studies we hypothesized that treatment of immunocompetent mice with bortezomib tailo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Psallidas, Ioannis, Karabela, Sophia P, Moschos, Charalampos, Sherrill, Taylor P, Kollintza, Androniki, Magkouta, Sophia, Theodoropoulou, Panagiota, Roussos, Charis, Blackwell, Timothy S, Kalomenidis, Ioannis, Stathopoulos, Georgios T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841124/ https://www.ncbi.nlm.nih.gov/pubmed/20219102 http://dx.doi.org/10.1186/1476-4598-9-56

Ejemplares similares

Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion
por: Magkouta, Sophia, et al.
Publicado: (2016)

Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications
por: Magkouta, Sophia, et al.
Publicado: (2018)

Malignant pleural effusion: from bench to bedside
por: Psallidas, Ioannis, et al.
Publicado: (2016)

Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion
por: Marazioti, Antonia, et al.
Publicado: (2013)

Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion
por: Merrick, Christopher, et al.
Publicado: (2019)

Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice
por: Doris, Konstantinos, et al.
Publicado: (2010)

CSF1/CSF1R signaling mediates malignant pleural effusion formation
por: Kosti, Chrysavgi N., et al.
Publicado: (2022)

Static and dynamic mechanics of the murine lung after intratracheal bleomycin
por: Manali, Effrosyni D, et al.
Publicado: (2011)

Mastic Oil Inhibits the Metastatic Phenotype of Mouse Lung Adenocarcinoma Cells
por: Loutrari, Heleni, et al.
Publicado: (2011)

Mutant KRAS promotes malignant pleural effusion formation
por: Αgalioti, Theodora, et al.
Publicado: (2017)

Clinical identification of malignant pleural effusions
por: Jia, Jianlong, et al.
Publicado: (2023)

Management of malignant pleural effusion: challenges and solutions
por: Penz, Erika, et al.
Publicado: (2017)

CD(8+ )T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis
por: Daniil, Zoe, et al.
Publicado: (2005)

Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
por: Klanova, Magdalena, et al.
Publicado: (2012)

Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
por: Rovina, Nikoletta, et al.
Publicado: (2007)

CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy
por: Magkouta, Sophia Fotiou, et al.
Publicado: (2021)

MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma
por: Magkouta, Sophia F., et al.
Publicado: (2023)

CD(8+ )T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis
por: Papiris, Spyros A, et al.
Publicado: (2007)

Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist
por: Papiris, Spyros A, et al.
Publicado: (2007)

Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion
por: Marazioti, Antonia, et al.
Publicado: (2014)

Pleural Fluid-to-Blood BNP Ratio May Contribute to Prognosis in Malignant Pleural Mesothelioma
por: Tsolaki, Vasiliki, et al.
Publicado: (2023)

The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
por: Varsamas, Charalampos, et al.
Publicado: (2020)

Advances in pleural disease
por: Psallidas, Ioannis, et al.
Publicado: (2016)

Pleural Effusion
por: Gray, Frank D.
Publicado: (1963)

Pleural Effusion
por: Brunton, T. Lauder
Publicado: (1898)

Pleural Effusion
por: Sherding, Robert G., et al.
Publicado: (2006)

Pleural Effusions
Publicado: (1877)

Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion
por: Saroglou, Maria, et al.
Publicado: (2010)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
por: Marazioti, Antonia, et al.
Publicado: (2018)

Device Occlusion of Native Pulmonary Blood Flow After Cavopulmonary Anastomosis With Persistent Pleural Effusions
por: Khan, Sophia, et al.
Publicado: (2022)

Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
por: Marazioti, A, et al.
Publicado: (2019)

Filarial pleural effusion
por: Gowrinath, K.
Publicado: (2011)

Tuberculous Pleural Effusion
por: Schlesinger, Shira A., et al.
Publicado: (2012)

Filariasis and pleural effusion
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Encysted Pleural Effusions
por: Viswanathan, R.
Publicado: (1946)

Cholesterol Pleural Effusion
por: Curran, Thomas M.
Publicado: (1948)

Fœtid Pleural Effusion
por: James, Alexander
Publicado: (1891)

The Treatment of Pleural Effusion
Publicado: (1893)

Cytodiagnosis of Pleural Effusions
por: Gulland, G. Lovell
Publicado: (1902)

Fœtid Pleural Effusion
por: James, Alexander
Publicado: (1891)

Cannot write session to /tmp/vufind_sessions/sess_uqpbt8809931ehcko081e46ce4